Graham (NYSE: GHC) and Cannabis Sativa (OTCMKTS:CBDS) are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.
Valuation and Earnings
This table compares Graham and Cannabis Sativa’s top-line revenue, earnings per share (EPS) and valuation.
Graham has higher revenue and earnings than Cannabis Sativa. Cannabis Sativa is trading at a lower price-to-earnings ratio than Graham, indicating that it is currently the more affordable of the two stocks.
This table compares Graham and Cannabis Sativa’s net margins, return on equity and return on assets.
This is a breakdown of current ratings and target prices for Graham and Cannabis Sativa, as provided by MarketBeat.com.
Graham has a beta of 0.75, indicating that its share price is 25% less volatile than the SP 500. Comparatively,